A new series examines the future of male infertility treatment, focusing on restoring testicular function. Pioneering techniques like microTESE and regenerative solutions are central to these advancements. The goal is to expand access to these critical treatments for men globally.
Peter N. Schlegel, a leading figure in male reproductive health and founder of New York Men’s Health Medical, is at the forefront of this research. His work includes identifying novel genetic causes of severe male infertility and developing advanced surgical methods.